Multiple Sclerosis (MS), a chronic inflammatory autoimmune disease of the central nervous system (CNS), is most commonly diagnosed in (young) adults, but can also affect children. Pediatric MS, also referred to as pediatric-onset MS (POMS), early-onset MS or juvenile MS, is generally defined as MS with an onset before the age of 16 years (sometimes before the age of 18 years). Between 3 and 10% of patients with MS present under 16 years of age and < 1% under 10 years of age. Pediatric MS is multiple sclerosis that begins in children or teens. About 98% have relapsing-remitting MS, versus 84% of adults with MS. This means that symptoms come and go (relapse and remit). When symptoms are gone, the disease is still able to progress.
Market Analysis: Journal of Pediatric Neurology and Medicine
Market Analysis: Journal of Pediatric Neurology and Medicine
Case Report: Journal of Pediatric Neurology and Medicine
Case Report: Journal of Pediatric Neurology and Medicine
Research Article: Journal of Pediatric Neurology and Medicine
Research Article: Journal of Pediatric Neurology and Medicine
Case Report: Journal of Pediatric Neurology and Medicine
Case Report: Journal of Pediatric Neurology and Medicine
Review Article: Journal of Pediatric Neurology and Medicine
Review Article: Journal of Pediatric Neurology and Medicine
Posters & Accepted Abstracts: Neurological Disorders
Posters & Accepted Abstracts: Neurological Disorders
Posters & Accepted Abstracts: Neurological Disorders
Posters & Accepted Abstracts: Neurological Disorders
Keynote: Neurological Disorders
Keynote: Neurological Disorders
Posters & Accepted Abstracts: Journal of Spine
Posters & Accepted Abstracts: Journal of Spine
Scientific Tracks Abstracts: Neurological Disorders
Scientific Tracks Abstracts: Neurological Disorders
Journal of Pediatric Neurology and Medicine received 68 citations as per Google Scholar report